- Previous Close
2.9200 - Open
2.8600 - Bid 2.0400 x 100
- Ask 3.4900 x 200
- Day's Range
2.6400 - 2.8600 - 52 Week Range
2.6400 - 31.4500 - Volume
16,472 - Avg. Volume
649,776 - Market Cap (intraday)
1.721M - Beta (5Y Monthly) 1.91
- PE Ratio (TTM)
-- - EPS (TTM)
-19.6700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
tivichealth.comRecent News: TIVC
View MorePerformance Overview: TIVC
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TIVC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TIVC
View MoreValuation Measures
Market Cap
1.72M
Enterprise Value
-280.77k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.04
Price/Book (mrq)
0.68
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-88.85%
Return on Equity (ttm)
-184.96%
Revenue (ttm)
780k
Net Income Avi to Common (ttm)
-5.66M
Diluted EPS (ttm)
-19.6700
Balance Sheet and Cash Flow
Total Cash (mrq)
2M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.27M